Edition:
United States

InspireMD Inc (NSPR.A)

NSPR.A on American Stock Exchange

0.94USD
2:07pm EDT
Change (% chg)

$-0.01 (-1.11%)
Prev Close
$0.95
Open
$0.90
Day's High
$0.95
Day's Low
$0.87
Volume
60,397
Avg. Vol
26,957
52-wk High
$15.25
52-wk Low
$0.85

Latest Key Developments (Source: Significant Developments)

Inspiremd Inc received approval to commercialize CGuard embolic prevention system
Monday, 14 Nov 2016 07:00am EST 

Inspiremd Inc :Inspiremd Inc - received regulatory approval to commercialize cguard embolic prevention system for treatment of carotid artery disease in Russia.  Full Article

InspireMD announces 1-for-25 reverse stock split
Wednesday, 28 Sep 2016 04:01pm EDT 

InspireMD Inc : Announces 1-for-25 reverse stock split .Post split, number of outstanding shares will be reduced from approximately 36 million to 1.4 million.  Full Article

Inspiremd non-GAAP net loss $0.16 per share
Tuesday, 9 Aug 2016 04:01pm EDT 

Inspiremd Inc : Revenue for q2 ended june 30, 2016 was $0.5 million compared to $0.7 million . Net loss for quarter ended june 30, 2016 was $0.19 per share . Non-Gaap net loss for quarter ended june 30, 2016 was $0.16 per share .Inspiremd reports financial results for the second quarter ended june 30, 2016.  Full Article

InspireMD amends loan & security agreement with Hercules Capital
Tuesday, 14 Jun 2016 08:00am EDT 

InspireMD Inc : InspireMD announces amendment to loan & security agreement with Hercules Capital . Announced that it has completed a restructuring of its existing debt. . Under terms of amendment, all parties have agreed to a deferral of payment of principal for a four month period beginning may 1st, 2016 .Company will be subject to certain additional covenants, and will pay a financing fee to lenders.  Full Article

InspireMD Names Dr. James Barry as President and CEO
Tuesday, 7 Jun 2016 08:00am EDT 

Inspiremd Inc : James Barry replaces Alan Milinazzo, who previously announced decision to step down as director, president and CEO in January 2016 . Prior to appointment as ceo, james barry served as inspiremd's coo since july 2014 . Barry replaces alan milinazzo . Milinazzo will continue to serve as an advisor to company. . Prior to appointment, barry served as inspiremd's chief operating officer since july 2014 .Inspiremd names dr. James barry as president and ceo.  Full Article

InspireMD's cguard highlighted at late-breaking clinical trial session
Tuesday, 17 May 2016 08:00am EDT 

Inspiremd Inc : Says Cguard Eps Reported Positive Results In Paradigm-101 .Breaking clinical trial session at the europcr 2016 conference.  Full Article

InspireMD Q1 loss per share $0.32
Tuesday, 10 May 2016 08:30am EDT 

InspireMD Inc : InspireMD reports financial results for the first quarter ended March 31, 2016 . Q1 non-GAAP loss per share $0.23 . Q1 loss per share $0.32 .Q1 revenue $600,000 versus $500,000.  Full Article

InspireMD Inc Announces Full Market Launch of CGuard(TM) Distributed by Penumbra at CIRSE Annual Congress
Monday, 28 Sep 2015 08:00am EDT 

InspireMD Inc:Says full market launch of the CGuard™ Embolic Prevention System for the treatment of carotid artery disease by its strategic distribution partner, Penumbra, Inc.  Full Article

InspireMD Inc Announces MGuard Prime Approval in Brazil
Monday, 27 Apr 2015 08:13am EDT 

InspireMD Inc:Says it received approval to commercialize MGuard Prime with MicroNet technology in Brazil.The approval was granted by the Agencia Nacional de Vigilancia Sanitaria (ANVISA).  Full Article

More From Around the Web

BRIEF-InspireMD reports Q3 loss per share $0.86

* InspireMD reports financial results for the third quarter ended September 30, 2016